Previous work has shown that there is a specific increase in expression of CTLA4, a negative regulator of T-cell receptor signaling, during tumor progression in a KRAS-driven murine PDAC model and that induction of MYC in a model of hepatocellular carcinoma elevates CTLA4 expression on T-cells53,54. Here, KRAS is linked to hepatocellular carcinoma.